CD14 and COVID-19: This is a pioneer study, which correlates the frequency of both CD33+CD11b+HLA-DR-CD14+ cells and CD33+CD11b+HLA-DR-CD66b+ cells to COVID-19 severity, as previous reports only highlighter the expansion of polymorphonuclear MDSC (17).